|
rs6457617 |
SNP |
PedAM |
snpId=rs6457617; pubmedId=18668548; geneId=3117; geneSymbol=HLA-DQA1; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Genome-wide association study of rheumatoid arthritis in the Spanish population: KLF12 as a risk locus for rheumatoid arthritis susceptibility.]; score=0.024484645; Year=2008; geneSymbol_dbSNP=NA; CHROMOSOME=6; POS=32696074; REF=C; ALT=T |
details
|
|
|
rs6496667 |
SNP |
PedAM |
snpId=rs6496667; pubmedId=22446963; geneId=342132; geneSymbol=ZNF774; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population.]; score=0.122367032; Year=2012; geneSymbol_dbSNP=GABARAPL3;ZNF774; CHROMOSOME=15; POS=90350436; REF=C; ALT=A |
details
|
|
|
rs6496667 |
SNP |
PedAM |
snpId=rs6496667; pubmedId=22446963; geneId=342132; geneSymbol=ZNF774; diseaseId=umls:C0003873; sourceId=GWASCAT; sentence=Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population.; score=0.122367032; Year=2012; geneSymbol_dbSNP=GABARAPL3;ZNF774; CHROMOSOME=15; POS=90350436; REF=C; ALT=A |
details
|
|
|
rs6496667 |
SNP |
PedAM |
snpId=rs6496667; pubmedId=22446963; geneId=23766; geneSymbol=GABARAPL3; diseaseId=umls:C0003873; sourceId=GWASCAT; sentence=Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population.; score=0.12; Year=2012; geneSymbol_dbSNP=GABARAPL3;ZNF774; CHROMOSOME=15; POS=90350436; REF=C; ALT=A |
details
|
|
|
rs6498169 |
SNP |
PedAM |
snpId=rs6498169; pubmedId=19221398; geneId=23274; geneSymbol=CLEC16A; diseaseId=umls:C0003873; sourceId=BeFree; sentence=The effect of the MHC2TA rs3087456G/rs4774C haplotype on RA susceptibility was confirmed, and the haplotype was found to be in negative linkage disequilibrium with the CLEC16A rs2903692A/rs6498169A haplotype.; score=0.00554839; Year=2010; geneSymbol_dbSNP=CLEC16A; CHROMOSOME=16; POS=11155472; REF=G; ALT=A |
details
|
|
|
rs6498169 |
SNP |
PedAM |
snpId=rs6498169; pubmedId=19221398; geneId=4261; geneSymbol=CIITA; diseaseId=umls:C0003873; sourceId=BeFree; sentence=A novel association of rs6498169 with a predisposition to RA was described which is consistent with previous MHC2TA results.; score=0.252539865; Year=2010; geneSymbol_dbSNP=CLEC16A; CHROMOSOME=16; POS=11155472; REF=G; ALT=A |
details
|
|
|
rs6500395 |
SNP |
PedAM |
snpId=rs6500395; pubmedId=22491018; geneId=9683; geneSymbol=N4BP1; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.]; score=0.002367032; Year=2013; geneSymbol_dbSNP=N4BP1; CHROMOSOME=16; POS=48587491; REF=T; ALT=C |
details
|
|
|
rs6520278 |
SNP |
PedAM |
snpId=rs6520278; pubmedId=19723899; geneId=1421; geneSymbol=CRYGD; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Two SNP were associated with RA in the joint analysis of all samples: rs6520278 (TIMP1) was associated with RA in general (p = 0.035) and rs3093457 (IL9R) with anti-CCP-positive RA patients (p = 0.037) and male RA patients (p = 0.010).; score=0.021986792; Year=2009; geneSymbol_dbSNP=SYN1; CHROMOSOME=X; POS=47588525; REF=C; ALT=T |
details
|
|
|
rs657075 |
SNP |
PedAM |
snpId=rs657075; pubmedId=23577190; geneId=306; geneSymbol=ANXA3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242638474; Year=2013; geneSymbol_dbSNP=NA; CHROMOSOME=5; POS=132094425; REF=G; ALT=A |
details
|
|
|
rs657075 |
SNP |
PedAM |
snpId=rs657075; pubmedId=22446963; geneId=1437; geneSymbol=CSF2; diseaseId=umls:C0003873; sourceId=GAD; sentence=[Our study identified nine loci newly associated with rheumatoid arthritis at a threshold of P < 5.0 A 10(-8), including B3GNT2, ANXA3, CSF2, CD83, NFKBIE, ARID5B, PDE2A-ARAP1, PLD4 and PTPN2.]; score=0.129424521; Year=2012; geneSymbol_dbSNP=NA; CHROMOSOME=5; POS=132094425; REF=G; ALT=A |
details
|
|
|
rs657075 |
SNP |
PedAM |
snpId=rs657075; pubmedId=23577190; geneId=9034; geneSymbol=CCRL2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.005710211; Year=2013; geneSymbol_dbSNP=NA; CHROMOSOME=5; POS=132094425; REF=G; ALT=A |
details
|
|
|
rs657075 |
SNP |
PedAM |
snpId=rs657075; pubmedId=23577190; geneId=7128; geneSymbol=TNFAIP3; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.167568474; Year=2013; geneSymbol_dbSNP=NA; CHROMOSOME=5; POS=132094425; REF=G; ALT=A |
details
|
|
|
rs657075 |
SNP |
PedAM |
snpId=rs657075; pubmedId=23577190; geneId=1437; geneSymbol=CSF2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.129424521; Year=2013; geneSymbol_dbSNP=NA; CHROMOSOME=5; POS=132094425; REF=G; ALT=A |
details
|
|
|
rs657075 |
SNP |
PedAM |
snpId=rs657075; pubmedId=23577190; geneId=116985; geneSymbol=ARAP1; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.000271442; Year=2013; geneSymbol_dbSNP=NA; CHROMOSOME=5; POS=132094425; REF=G; ALT=A |
details
|
|
|
rs657075 |
SNP |
PedAM |
snpId=rs657075; pubmedId=23577190; geneId=122618; geneSymbol=PLD4; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242638474; Year=2013; geneSymbol_dbSNP=NA; CHROMOSOME=5; POS=132094425; REF=G; ALT=A |
details
|
|
|
rs657075 |
SNP |
PedAM |
snpId=rs657075; pubmedId=23577190; geneId=10678; geneSymbol=B3GNT2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.123181358; Year=2013; geneSymbol_dbSNP=NA; CHROMOSOME=5; POS=132094425; REF=G; ALT=A |
details
|
|
|
rs657075 |
SNP |
PedAM |
snpId=rs657075; pubmedId=23577190; geneId=84159; geneSymbol=ARID5B; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.242909916; Year=2013; geneSymbol_dbSNP=NA; CHROMOSOME=5; POS=132094425; REF=G; ALT=A |
details
|
|
|
rs657075 |
SNP |
PedAM |
snpId=rs657075; pubmedId=23577190; geneId=9308; geneSymbol=CD83; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.123267234; Year=2013; geneSymbol_dbSNP=NA; CHROMOSOME=5; POS=132094425; REF=G; ALT=A |
details
|
|
|
rs657075 |
SNP |
PedAM |
snpId=rs657075; pubmedId=23577190; geneId=5771; geneSymbol=PTPN2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Genetic factors regarded as putative risk factors were RA-susceptible polymorphisms identified by the Japanese GWAS meta-analysis, including HLA-DRB1 (shared epitope, SE), rs2240340 (PADI4), rs2230926 (TNFAIP3), rs3093024 (CCR6), rs11900673 (B3GNT2), rs2867461 (ANXA3), rs657075 (CSF2), rs12529514 (CD83), rs2233434 (NFKBIE), rs10821944 (ARID5B), rs3781913 (PDE2A-ARAP1), rs2841277 (PLD4) and rs2847297 (PTPN2).; score=0.248458305; Year=2013; geneSymbol_dbSNP=NA; CHROMOSOME=5; POS=132094425; REF=G; ALT=A |
details
|
|
|
rs660895 |
SNP |
PedAM |
snpId=rs660895; pubmedId=23678157; geneId=3118; geneSymbol=HLA-DQA2; diseaseId=umls:C0003873; sourceId=BeFree; sentence=Among these associations, we found that 8 single-nucleotide polymorphisms (SNP; rs1600249, rs2736340, rs3093023, rs3093024, rs4810485, rs615672, rs660895, and rs9272219) serve as cis-effect regulators of the corresponding eQTL genes (BLK and CD4 in non-HLA region; CCR6, HLA-DQA1, and HLA-DQB1 in HLA region) that also were differentially expressed in RA-related cell groups.; score=0.123452799; Year=2014; geneSymbol_dbSNP=NA; CHROMOSOME=6; POS=32609603; REF=A; ALT=G |
details
|
|
